How Should Clinics Control AI Agents While They Are Running in 2026?

Direct Answer: Runtime Controls for Clinical AI Agents

Runtime AI agent controls are the permissions, restrictions, monitoring, and emergency actions applied while an autonomous or semi-autonomous agent is operating—not merely before deployment. A clinic might use them to limit an agent to approved patient directories, block outbound messages, require approval before changing care tasks, cap database queries, and stop execution if sensitive data leaves an approved system. In a care-coordination setting, the practical objective is not to make an agent “autonomous”; it is to define exactly what the system may do without waiting for a person, for how long, and under what conditions it must stop. This distinction matters because a static prompt or pre-deployment test cannot account for every tool result, conversation, permission change, or chain of actions encountered during execution. NVIDIA’s October 2025 OpenShell announcement illustrates the broader movement toward a runtime control and enforcement layer for AI agents, while projects and companies including Kontext Security, Prismor, Halo, and Runtm reflect demand for more explicit controls around agent-built software.

Also worth reading: What Risk Controls Should Clinics Require Before Deploying Clinical AI Agents in 2026? · How Will Generative AI Care Coordination Agents Work in Clinics by 2027? · How should independent clinics and care networks go about optimizing primary care revenue cycles while managing chronic disease care gaps?

For getpulse.care’s audience, runtime controls should be treated as operational governance for software that can read patient-pulse information, trigger outreach, update task status, or recommend next steps to care teams. They are especially relevant when an agent can call external tools because the model’s text generation is only one part of the risk. The meaningful security boundary is the complete execution path: inputs, retrieved records, tool selection, credentials, side effects, and outputs. A strong control design therefore combines least-privilege access, scoped tools, approval gates, logging, rate limits, data-loss prevention, and a reliable kill switch. No single feature is sufficient, and many routine workflows will need fewer controls than high-risk clinical operations.

How Runtime Agent Controls Actually Work

A runtime control sits between the AI agent and an action or resource and evaluates what the agent is trying to do at that moment. If the agent attempts to search an approved scheduling system, the control may verify its identity, patient scope, purpose, and permitted operation before allowing the call. If it attempts to export a full patient list, export sensitive data, change a medication-related field, or send a message to an unverified recipient, the control may deny or quarantine the action. Some systems use deterministic policy, such as blocking every write outside two named fields; others combine policy rules with model-based classification, sandboxing, or human review. The best production designs favor deterministic enforcement for hard boundaries because a probabilistic classifier should not be the final authority on a clear prohibition.

Controls can govern identity, data, tools, time, cost, and autonomy. Identity controls bind each action to a specific agent, service account, user, clinic, and patient or task scope. Data controls classify records and restrict fields, destinations, and retention periods. Tool controls expose only necessary functions and validate their arguments rather than accepting arbitrary commands. Behavioral controls set transaction limits, recursion limits, maximum run times, budgets, and escalation thresholds. A sensible pilot might permit 20 read operations and 5 draft messages per patient case, prohibit final sends, and halt the run after 10 minutes or 2,000 tool calls. Those numbers are examples rather than universal standards; actual thresholds should come from workflow testing, risk assessment, vendor documentation, and the clinic’s governance requirements.

Why Static Guardrails Are Not Enough for Care Coordination

Static guardrails evaluate prompts, model output, or a planned workflow before execution. That is useful, but it leaves a gap between what was approved and what actually happens once the agent interacts with live systems. An agent may encounter a newly discovered field, misinterpret a note, receive tool output containing unexpected data, retry a failed operation, or combine several individually harmless actions into a harmful sequence. This is why runtime security discussions in 2025 and 2026 moved toward enforcing permissions during execution rather than relying only on development-time alignment. The research reference “Research AI model unexpectedly modified its own code to extend runtime,” published by Ars Technica in 2024, is a useful reminder that code-bearing agents can change behavior outside their original path, although it should not be treated as direct evidence about clinical-agent failure rates.

Clinical workflows add organizational constraints that ordinary software tests may miss. A patient-pulse platform may need to distinguish a coordinator’s authorized review from an AI service account, separate draft outreach from sent communication, and prevent one clinic tenant from seeing another tenant’s records. Runtime policy can also require a second person to approve messages involving discharge, medication adherence, escalation, or other sensitive contexts. Yet over-control can make an agent unusable: requiring a clinician to approve every status read would erase much of its value, while blocking every external message would turn a coordination assistant into a closed reporting tool. The appropriate design begins with the smallest useful workflow and introduces approval only where incorrect action could cause patient harm, privacy loss, financial harm, or substantial rework.

Practical Controls to Implement Before Production Use

The first practical step is to inventory every action the agent can take, including indirect actions through APIs and code. Teams should document each input, data source, tool, credential, destination, expected side effect, and recovery path. They can then classify actions by impact, reversibility, data sensitivity, and whether a human currently reviews the result. A read from an approved patient-pulse dashboard may receive a lower control level than creating a triage task, sending a message, modifying a care plan, or exporting records. This inventory should cover error paths, because retries, loops, and fallback tools are often overlooked. A workflow diagram with 100 possible agent actions is more useful than a broad claim that the agent is “safe.”

Next, give the agent a dedicated service identity rather than reusing a clinician’s broad credentials. Restrict that identity to named systems, fields, tenants, and operations, and rotate credentials on a defined schedule. Use allowlists for approved tools and destinations, validate tool arguments, and deny access to raw credentials or unrestricted code execution where possible. Add automatic termination for excessive run time, token use, tool calls, cost, repeated failures, and unusual data volume. For example, an agent exceeding 3 failed actions on the same record should pause for review rather than continue trying alternatives. Human approval should be explicit, time-bound, and visible; approving one send should not grant permission for an entire campaign.

The rollout should begin in shadow mode, where the agent can prepare recommendations or drafts without changing production records. Compare its decisions with the care team’s normal process over a representative period, such as 2 to 4 weeks, and record false approvals, blocked legitimate actions, latency, and manual corrections. Only then enable low-risk writes, while keeping high-risk actions reversible or approval-gated. A useful threshold is not “zero errors” but a documented tolerance based on clinical risk: for example, no unauthorized disclosure, no unreviewed high-risk patient contact, and fewer than 1% of routine cases requiring correction. That 1% figure is a policy example, not a published clinical standard, and it must be set by the responsible organization.

Comparison: Build, Buy, or Use Platform Controls

There is no universal winner among open-source runtimes, commercial runtime-security platforms, and controls built into an existing agent platform. The right choice depends on the clinic’s technical maturity, cloud requirements, audit obligations, model variety, and tolerance for maintenance. Open-source projects can provide visibility and flexibility, while commercial products may reduce operational effort; neither automatically guarantees safe behavior. NVIDIA OpenShell is aimed at securing and controlling autonomous AI agents at runtime, and vendors such as Kontext Security focus specifically on runtime control requirements. A care platform may also enforce tenant and workflow permissions even if it does not market itself as a general AI-agent security product.

For getpulse.care, a practical decision may combine approaches rather than select only one. A clinic network with experienced platform engineers and strict customization needs could use an open-source runtime beneath a commercial identity layer. A smaller clinic may prefer a managed platform with prebuilt EHR or messaging connectors, but should verify tenant isolation, data residency, audit exports, retention, and incident-notification terms before connecting patient data. It should also test whether the vendor can express patient-scope restrictions and approval rules, rather than merely detecting suspicious prompts. Price comparisons are often unavailable because vendors price by users, protected agents, tool calls, data volume, deployment model, or enterprise support, so any budget should include implementation and ongoing review rather than rely on a headline subscription alone.

Common Mistakes That Produce False Confidence

A frequent mistake is treating a system prompt as a security boundary. Instructions such as “do not disclose protected health information” can reduce accidental behavior, but they are not equivalent to database permissions, network isolation, or transaction policies. Another mistake is giving a general-purpose agent unrestricted access to a production API because a demo only used one function. Tool descriptions can change, APIs can return unexpected fields, and a model can compose valid operations in an unsafe order. Teams should test policy under prompt injection, malicious documents, credential requests, repeated tool failures, indirect prompt content, and attempts to cross tenant boundaries.

The opposite mistake is disabling the agent because a kill switch is easy to conceptualize but poorly defined. A control that only logs an incident does not prevent continued disclosure, while a switch that stops all care coordination may create a larger operational problem. The pause procedure should identify who can stop a run, how the system freezes queued actions, what gets preserved for investigation, and how normal service resumes after approval. The team should also avoid measuring safety only by the number of blocked attacks. Excessive false positives can cause staff to bypass the system or approve warnings without reading them, so precision, review time, workflow disruption, and successful legitimate completion matter too.

Finally, avoid assuming that a new runtime feature is already compatible with a clinical system. A control plane may sandbox agent code without validating whether the agent can correctly read a patient’s latest status, and it may block a tool needed for escalation. Security controls should be tested together with clinical operations, including downtime, stale data, duplicate outreach, account changes, and staff turnover. A mature program accepts that control tuning is continuous rather than treating launch as proof that the system is finished.

When a Clinic Should Act and What to Budget

A clinic should act before an agent can write to a production system, communicate externally, access broad patient data, execute code, or trigger operational work. The strongest trigger is not the model’s size or whether it has a chat interface; it is the consequence and reversibility of its actions. A read-only internal summary may begin with lighter controls, while automatic patient outreach, care-plan changes, discharge decisions, or record exports require a more formal review. Organizations should involve security, privacy, clinical operations, compliance, IT, and the people who manage the affected workflow. Depending on jurisdiction, health-data obligations can include privacy, security, breach-response, and records-management duties, but legal requirements must be assessed for the specific deployment rather than inferred from this article.

Budgets should include more than the agent-control license. A modest pilot might reserve several thousand dollars for integration and policy design, tens of thousands for a cross-system production deployment, and a recurring operating cost for identity, logging, monitoring, support, and review; these are planning ranges, not vendor quotes. The supplied research mentions an $8 million round for Arrakis around AI-agent runtime security and a $4 million emergence financing for Kontext Security, which signals investor attention but says nothing about what a clinic will pay. The cost of unsafe operation can include staff rework, privacy incidents, reputational harm, and interrupted care coordination, so comparing a small license fee with those outcomes can be misleading. Procurement should ask for total cost over 12 to 24 months, data export terms, incident support, implementation effort, and the price of additional agents or tenants.

A go/no-go decision should be evidence-based. Proceed when the team can name the permitted actions, demonstrate isolation in testing, measure review burden, and recover from a simulated stop within a defined target such as 15 minutes. Pause when staff cannot explain why an action was blocked, when sensitive data reaches an unapproved destination, or when no accountable owner can pause the agent. A successful first release may be a controlled recommendation system with no autonomous clinical authority. That may appear less ambitious than a fully autonomous agent, but it is often the more defensible starting point for patient-pulse operations because it improves visibility and coordination without assigning irreversible decisions to software.

A Recommended Operating Model for Care Networks

A care network can organize runtime governance around four layers: policy, enforcement, observation, and review. The policy layer states what the agent is intended to do, which data it may use, and which actions require approval. The enforcement layer applies those rules at the identity, tool, data, and network boundaries. The observation layer records inputs, tool calls, decisions, outputs, costs, and policy events in a form authorized staff can review. The review layer samples routine runs, investigates exceptions, and changes rules when workflows or risks change. The layers should be connected: a logged denial that nobody analyzes is not much better than no logging, while a policy not represented in the runtime cannot be reliably enforced.

Ownership should be explicit. A clinical operations lead should define acceptable workflow behavior; an IT or security owner should control the service identity and integrations; a privacy or compliance owner should review data use; and a named on-call person should handle immediate suspension. The system should retain enough evidence to reconstruct what happened without recording unnecessary clinical detail. That means considering access controls for logs themselves, because an audit trail containing patient information can become another sensitive dataset. Retention should be proportionate to investigation and contractual needs, with a documented deletion process rather than an indefinite archive. Vendors should explain whether evidence can be exported and whether the customer can retrieve it if the vendor contract ends.

For a platform such as getpulse.care, the practical value of runtime controls is to make patient-pulse workflows more dependable for clinics and care networks, not to promote unrestricted AI activity. The system can present a coordinator with a prioritized queue, prepare a draft follow-up, and pause for approval before any external communication. If an agent encounters conflicting status data, repeated failed calls, an unfamiliar risk signal, or an attempted cross-tenant request, it can stop and explain the exception. This design supports oversight while keeping routine work efficient. It also creates a useful measurement base: compare time to coordinator review, percentage of drafts accepted without major edits, number of blocked unsafe actions, false-positive rate, and time to recover after a pause. Those measures connect security controls to actual care operations rather than treating governance as an abstract compliance exercise.